Stampfl Sibylle, Bellemann Nadine, Stampfl Ulrike, Radeleff Boris, Lopez-Benitez Ruben, Sommer Christof-Matthias, Thierjung Heidi, Berger Irina, Richter Goetz M
Department of Diagnostic Radiology, University of Heidelberg Medical Center, INF 110, 69120 Heidelberg, Germany.
J Vasc Interv Radiol. 2008 Apr;19(4):577-86. doi: 10.1016/j.jvir.2008.01.011.
To evaluate the pattern of recanalization and specific inflammatory reaction after superselective embolization with four commercially available spherical embolic agents of different sizes in the mini pig kidney model.
In 40 mini pigs, the lower poles of both kidneys were superselectively embolized with Embozene, Embosphere, Bead Block, and Contour SE particles in sizes of 40-120 mircom (Embozene, Embosphere) and 100-300 microm, 500-700 microm, and 700-900 microm (Embozene, Embosphere, Bead Block, Contour SE). After a follow-up time of 4 or 12 weeks, recanalization was determined with angiography. Pathologic and histologic evaluation of the kidneys was performed, and the Banff 97 classification was used to evaluate the extent of vessel wall inflammation. Macroscopically visible ischemic changes were evaluated by using a specific ischemia score.
After embolization with Embozene microspheres, larger Embosphere particles, and Bead Block and Contour SE particles, the absence of inflammation or a low inflammation score was observed. Significantly elevated inflammation scores were evident with small Embosphere particles after 4 weeks (mean score, 1.21 +/- 1.0). Distinct recanalization occurred with Contour SE particles (100% recanalization with 100-300-microm particles at 12 weeks, 500-700-microm particles at 4 and 12 weeks, and 700-900-microm particles at 4 weeks). Ischemia scores were highest in the target area in all specimens. Mildly elevated ischemia scores in nontarget tissue areas were indicative of minor nontarget embolization.
Except for small Embosphere particles at 4 weeks, the absence of inflammatory reaction to the embolization procedure or only low inflammatory changes were observed with all embolic agents, particle sizes, and follow-up intervals. Recanalization was evident with all embolic agents; however, it was pronounced with Contour SE particles.
在小型猪肾脏模型中,评估使用四种市售不同大小的球形栓塞剂进行超选择性栓塞后再通模式和特定炎症反应。
对40只小型猪的双肾下极进行超选择性栓塞,栓塞剂分别为Embozene、Embosphere、Bead Block和Contour SE颗粒,粒径分别为40 - 120微米(Embozene、Embosphere)以及100 - 300微米、500 - 700微米和700 - 900微米(Embozene、Embosphere、Bead Block、Contour SE)。随访4周或12周后,通过血管造影确定再通情况。对肾脏进行病理和组织学评估,并使用Banff 97分类法评估血管壁炎症程度。通过特定的缺血评分评估宏观可见的缺血变化。
使用Embozene微球、较大的Embosphere颗粒、Bead Block和Contour SE颗粒栓塞后,观察到无炎症或炎症评分较低。4周后,小Embosphere颗粒出现明显升高的炎症评分(平均评分,1.21±1.0)。Contour SE颗粒出现明显再通(12周时100 - 300微米颗粒再通率为100%,4周和12周时500 - 700微米颗粒再通,4周时700 - 900微米颗粒再通)。所有标本的靶区缺血评分最高。非靶组织区域轻度升高的缺血评分表明存在轻微的非靶栓塞。
除4周时的小Embosphere颗粒外,所有栓塞剂、粒径和随访间隔均观察到对栓塞程序无炎症反应或仅有低炎症变化。所有栓塞剂均出现再通;然而,Contour SE颗粒的再通情况更为明显。